ARGX
arGEN-X SpADR (ARGX)
NASDAQ
$875.46+$22.96 (+2.69%)
Price as of Jun 25, 2026 9:35 AM EDT
  • $53.0B
    Market Cap
  • 52.09%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
35.5M
+254.41%
10.0M
-97.98%
Cost of Revenue
450.7M
+98.28%
227.3M
+92.89%
117.8M
+300.38%
29.4M
N/A
Gross Profit
-450.7M
+98.28%
-227.3M
+176.16%
-82.3M
+324.13%
-19.4M
-103.90%
Sales and Marketing Expense
1.4B
+29.54%
1.1B
+422.07%
202.1M
N/A
N/A
N/A
Research and Development Expense
-1.4B
+38.71%
-983.4M
+14.42%
-859.5M
+29.57%
-663.4M
+14.27%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
1.4B
-35.23%
2.1B
+196.48%
711.9M
+50.79%
472.1M
+53.47%
Operating Profit
1.1B
+4,966.57%
-21.7M
-94.91%
-425.0M
-40.99%
-720.3M
+106.55%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
1.3B
+55.10%
833.0M
+382.34%
-295.1M
-58.42%
-709.6M
+73.81%
Income Taxes
-13.4M
-98.20%
-747.9M
+7,819.73%
-9.4M
-52.11%
-19.7M
-331.40%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
1.3B
+55.10%
833.0M
+382.34%
-295.1M
-58.42%
-709.6M
+73.81%
Net Income from Continuing Operations Applicable to Common
1.3B
+55.10%
833.0M
+382.34%
-295.1M
-58.42%
-709.6M
+73.81%
Basic EPS and Net Income
21.08
+51.44%
13.92
+369.77%
-5.16
-60.46%
-13.05
+63.33%
Diluted EPS and Net Income
19.57
+53.13%
12.78
+347.67%
-5.16
-60.46%
-13.05
+63.33%
Basic Weighted Average Shares
61.3M
+2.41%
59.9M
+4.70%
57.2M
+5.13%
54.4M
+6.47%
Diluted Weighted Average Shares
61.3M
+2.41%
59.9M
+4.70%
57.2M
+5.13%
54.4M
+6.47%
Balance Sheet
Cash and Cash Equivalents
3.5B
+132.76%
1.5B
-26.79%
2.0B
+155.87%
800.7M
-40.00%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
3.5B
+132.76%
1.5B
-26.79%
2.0B
+155.87%
800.7M
-40.00%
Total Current Assets
6.9B
+41.29%
4.9B
+18.41%
4.1B
+48.65%
2.8B
+9.09%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
22.7M
+39.68%
16.2M
+2.46%
Total Long-Term Assets
1.8B
+35.18%
1.3B
+215.11%
418.7M
+16.29%
360.1M
+17.17%
Total Assets
8.7B
+39.99%
6.2B
+36.55%
4.5B
+44.93%
3.1B
+9.96%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
1.3B
+97.07%
669.9M
+58.38%
423.0M
+39.94%
302.3M
+0.34%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
39.4M
+14.85%
34.3M
+56.31%
22.0M
+20.09%
18.3M
+23.46%
Total Liabilities
1.4B
+93.06%
704.2M
+58.27%
445.0M
+38.80%
320.6M
+1.43%
Retained Earnings
-279.8M
-82.20%
-1.6B
-34.64%
-2.4B
+13.98%
-2.1B
+50.68%
Total Stockholders Equity
7.3B
+33.19%
5.5B
+34.19%
4.1B
+45.63%
2.8B
+11.03%
Total Shares Outstanding
61.9M
+1.85%
60.8M
+2.65%
59.2M
+6.86%
55.4M
+7.21%
Cash Flow
Cash from Operating Activities
685.2M
+928.06%
-82.7M
-80.31%
-420.3M
-51.28%
-862.8M
+42.19%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
984.0M
+237.13%
-717.6M
-332.83%
308.2M
+166.83%
-461.2M
+32.88%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
233.0M
-16.71%
279.8M
-79.07%
1.3B
+58.43%
843.8M
-24.75%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
-231.62%
+19.67%
-193.55%
N/A
Operating Margin
N/A
N/A
N/A
N/A
-1,196.21%
-83.35%
-7,184.73%
+10,144.71%
Return on Assets
17.36%
+11.96%
15.51%
+301.71%
-7.69%
-67.58%
-23.71%
+36.73%
Return on Equity
20.15%
+16.08%
17.36%
+303.35%
-8.54%
-67.82%
-26.54%
+26.70%
Revenue Growth
N/A
N/A
N/A
N/A
254.41%
+359.64%
-97.98%
-107.74%
Current Ratio
5.23
-28.31%
7.29
-25.23%
9.75
+6.22%
9.18
+8.72%
Cash Ratio
2.64
+18.11%
2.24
-53.78%
4.84
+82.85%
2.65
-40.21%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow